Welcome to our dedicated page for Inuvo SEC filings (Ticker: INUV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inuvo, Inc. filings document an AI-driven advertising technology issuer, its common stock, governance matters and material corporate events. Recent Form 8-K disclosures cover results of operations, preliminary revenue information, convertible-note financing and registration rights, settlement proceeds, executive appointments, and amendments to service agreements involving its Vertro subsidiary.
Inuvo proxy materials describe annual meeting voting matters, including director elections and ratification of the independent registered public accounting firm. The filing record also documents common-stock issuance limits under NYSE American rules, exhibits for material agreements, Regulation FD updates, and operating disclosures tied to IntentKey, Platform activity and digital advertising technology.
Inuvo, Inc. director Kenneth Ewell Lee reported the conversion of restricted stock units into common shares. On 01/08/2026, 3,000 restricted stock units were converted into 3,000 shares of Inuvo common stock at a price of $0.0000 per share through a transaction coded "M". After this transaction, Lee directly beneficially owned 54,500 shares of Inuvo common stock.
The filing notes that the share amounts were adjusted to reflect a 1-for-10 reverse stock split that occurred on June 10, 2025, and that each restricted stock unit represents a contingent right to receive one share of Inuvo common stock.
Inuvo, Inc. director Gordon J. Cameron reported a stock-based compensation transaction. On January 8, 2026, 3,000 restricted stock units were converted into 3,000 shares of Inuvo common stock at an exercise price of $0.0000, reflecting the vesting and settlement of equity awards rather than an open-market purchase. Following this transaction, Cameron beneficially owns 57,910 shares of Inuvo common stock directly and an additional 663 shares indirectly through his spouse. The reported share amounts have been adjusted to reflect a 1-for-10 reverse stock split that occurred on June 10, 2025.
Inuvo, Inc. reported that Chief Operating Officer and director Robert C. Buchner acquired common stock through the settlement of equity awards. On January 8, 2026, 3,000 restricted stock units were converted into 3,000 shares of common stock at an exercise price of $0.0000 per share. Following this transaction, Buchner directly holds 3,000 shares of Inuvo common stock. The number of restricted stock units and underlying shares reflects a 1-for-10 reverse stock split that occurred on June 10, 2025.
Inuvo, Inc. director Jonathan Bond reported the conversion of 3,000 restricted stock units into 3,000 shares of common stock on January 8, 2026. The Form 4 shows this as a code "M" transaction at a price of $0.0000 per share, indicating an exercise of equity awards rather than an open-market purchase.
After this transaction, Bond directly owns 12,000 shares of Inuvo common stock. The filing notes that the figures have been adjusted for a 1-for-10 reverse stock split that occurred on June 10, 2025. The derivative position in these restricted stock units is now reported as 0, reflecting that all 3,000 units referenced here have been converted into common shares.
Inuvo, Inc. director Kenneth Ewell Lee reported a new equity award. On 01/02/2026, he received 3,000 restricted stock units, each representing a contingent right to receive one share of Inuvo common stock. The units are listed as a derivative security with a conversion price of $0.0000 and are exercisable beginning 01/04/2027, with an expiration date of 01/04/2027. Following this transaction, he beneficially owns 3,000 derivative securities directly.
Inuvo, Inc. reported that one of its directors acquired equity-based compensation in the form of derivative securities. On 01/02/2026, the director received 3,000 restricted stock units, each representing a contingent right to receive one share of Inuvo common stock. The restricted stock units were acquired at a price of $0.0000 per unit and are listed as directly owned derivative securities. Following this grant, the director beneficially owns 3,000 derivative securities tied to Inuvo common stock, with the units shown as exercisable and expiring on 01/04/2027.
Inuvo, Inc. director Jonathan Bond reported receiving a grant of 3,000 restricted stock units of the company’s common stock. The Form 4 shows the RSU transaction date as 01/02/2026, with the units listed as directly owned. Each restricted stock unit represents a contingent right to receive one share of Inuvo common stock, and the RSUs have a date exercisable and expiration date of 01/04/2027. The transaction is reported as an acquisition of derivative securities at a stated price of $0.0000 per RSU.
Inuvo, Inc. reported that its wholly owned subsidiary Vertro, Inc. entered into an Extension Amendment to its Google Services Agreement with Google LLC. The amendment, signed on December 15, 2025 and effective as of December 31, 2025, extends the agreement’s term by one additional month, moving the contract’s expiration date to January 30, 2026.
A copy of the amendment is filed as Exhibit 10.1, providing the detailed terms of this material definitive agreement between Vertro and Google.
Inuvo, Inc. disclosed an insider equity transaction involving its Chief Financial Officer, Wallace D. Ruiz. On December 11, 2025, 14,100 restricted stock units converted into an equal number of common shares of Inuvo common stock at an exercise price of $0.0000 per share.
On the same date, 6,999 common shares were disposed of at $3.01 per share. Following these transactions, Ruiz directly beneficially owned 117,640 shares of Inuvo common stock. The RSU amount was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 10, 2025.
Inuvo, Inc. Chairman and CEO Richard K. Howe, who also serves as a director, reported stock transactions dated 12/11/2025. He acquired 46,002 shares of common stock at $0.0000 upon settlement of restricted stock units and disposed of 25,873 shares at $3.01 per share. After these transactions, he beneficially owned 504,136 shares of Inuvo common stock directly. The filing states that each restricted stock unit represented a right to receive one share of common stock and that the share amounts were adjusted for a 1-for-10 reverse stock split that occurred on June 10, 2025.